Lack of self-administration of cocaine in dopamine D1 receptor knock-out mice

Journal of Neuroscience

Volumn 27, Issue 48, 2007, Pages 13140-13150

  Caine, S Barak ^a   Thomsen, Morgane ^a   Gabriel, Kara I ^a   Berkowitz, Jill S ^a   Gold, Lisa H ^b   Koob, George F ^b   Tonegawa, Susumu ^c   Zhang, Jianhua ^d   Xu, Ming ^e  

^a MCLEAN HOSPITAL   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^d University of Alabama at Birmingham   (United States)

^e UNIVERSITY OF CHICAGO   (United States)

Author keywords

Cocaine; D1; Dopamine; Knock out; Mouse; Self administration

Indexed keywords

3 ALLYL 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; COCAINE; DOPAMINE 1 RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; OPIATE AGONIST; QUINELORANE; REMIFENTANIL;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; C57BL 6 MOUSE; CONTROLLED STUDY; DRUG INHIBITION; FEMALE; FOOD INTAKE; GENE TARGETING; GENOTYPE; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; BENZAZEPINES; COCAINE; CONDITIONING, OPERANT; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; DOPAMINE UPTAKE INHIBITORS; DRUG ADMINISTRATION SCHEDULE; DRUG INTERACTIONS; HYPNOTICS AND SEDATIVES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOTOR ACTIVITY; PIPERIDINES; RECEPTORS, DOPAMINE D1; REINFORCEMENT (PSYCHOLOGY); SELF ADMINISTRATION; STATISTICS, NONPARAMETRIC;

EID: 36849040558     PISSN: 02706474     EISSN: 02706474     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.2284-07.2007     Document Type: Article

References (70)

1. Barr JE, Holmes DB, Ryan LJ, Sharpless SK (1979) Techniques for the chronic cannulation of the jugular vein in mice. Pharmacol Biochem Behav 11:115-118.
2. Barrett AC, Miller JR, Dohrmann JM, Caine SB (2004) Effects of dopamine indirect agonists and selective D1-like and D2-like agonists and antagonists on cocaine self-administration and food-maintained responding in rats. Neuropharmacology 47 [Suppl 1]:256-273.
3. Bergman J, Kamien JB, Spealman RD (1990) Antagonism of cocaine self-administration by selective dopamine D1 and D2 antagonists. Behav Pharmacol 1:355-363.
4. Caine SB, Koob GF (1993) Modulation of cocaine self-administration in the rat through D-3 dopamine receptors. Science 260:1814-1816.
5. Caine SB, Koob GF (1994) Effects of dopamine D-1 and D-2 antagonists on cocaine self-administration under different schedules of reinforcement in the rat. J Pharmacol Exp Ther 270:209-218.
6. Caine SB, Koob GF (1995) Pretreatment with the dopamine agonist 7-OH-DPAT shifts the cocaine self-administration dose-effect function to the left under different schedules in the rat. Behav Pharmacol 6:333-347.
7. Caine SB, Lintz R, Koob GF (1993) Intravenous drug self-administration techniques in animals. In: Behavioral neuroscience: a practical approach (Sahgal A, ed), pp 117-143. Oxford: Oxford UP.
8. Caine SB, Negus SS, Mello NK, Bergman J (1999a) Effects of dopamine D(1-like) and D(2-like) agonists in rats that self-administer cocaine. J Pharmacol Exp Ther 291:353-360.
9. Caine SB, Negus SS, Mello NK (1999b) Method for training operant responding and evaluating cocaine self-administration behavior in mutant mice. Psychopharmacology (Berl) 147:22-24.
10. Caine SB, Negus SS, Mello NK (2000a) Effects of dopamine D(1-like) and D(2-like) agonists on cocaine self-administration in rhesus monkeys: rapid assessment of cocaine dose-effect functions. Psychopharmacology (Berl) 148:41-51.
11. Caine SB, Negus SS, Mello NK, Bergman J (2000b) Effects of dopamine D1-like and D2-like agonists in rats trained to discriminate cocaine from saline: influence of experimental history. Exp Clin Psychopharmacol 8:404-414.
12. 2 receptor antagonists. J Neurosci 22:2977-2988.
13. Caine SB, Gabriel KI, Berkowitz JS, Zhang J, Xu M (2003) Cocaine self-administration in dopamine D3 receptor knockout mice. Presented at the Annual Meeting of the College on Problems of Drug Dependence, Bal Harbour, FL, June.
14. Carlson JH, Bergstrom DA, Walters JR (1987) Stimulation of both D1 and D2 dopamine receptors appears necessary for full expression of postsynaptic effects of dopamine agonists: a neurophysiological study. Brain Res 400:205-218.
15. Chiamulera C, Epping-Jordan MP, Zocchi A, Marcon C, Cottiny C, Tacconi S, Corsi M, Orzi F, Conquet F (2001) Reinforcing and locomotor stimulant effects of cocaine are absent in mGluR5 null mutant mice. Nat Neurosci 4:873-874.
16. Clark D, White FJ (1987) D1 dopamine receptor - the search for a function: a critical evaluation of the D1/D2 dopamine receptor classification and its functional implications. Synapse 1:347-388.
17. Cooper DC, Hu X-T, White FJ (1998) Alterations in dopamine neurotransmission produced by genetic knockouts of dopamine D1 receptors. In: Dopamine receptor subtypes: from basic science to clinical application (Jenner P, Demirdamar R, ed). Amsterdam: IOS.
18. Cromwell HC, Berridge KC, Drago J, Levine MS (1998) Action sequencing is impaired in D1A-deficient mutant mice. Eur J Neurosci 10:2426-2432.
19. El-Ghundi M, Fletcher PJ, Drago J, Sibley DR, O'Dowd BF, George SR (1999) Spatial learning deficit in dopamine D(1) receptor knockout mice. Eur J Pharmacol 383:95-106.
20. Fetsko LA, Xu R, Wang Y (2003) Alterations in D1/D2 synergism may account for enhanced stereotypy and reduced climbing in mice lacking dopamine D2L receptor. Brain Res 967:191-200.
21. Gerfen CR, Keefe KA, Gauda EB (1995) D1 and D2 dopamine receptor function in the striatum: coactivation of D1- and D2-dopamine receptors on separate populations of neurons results in potentiated immediate early gene response in D1-containing neurons. J Neurosci 15:8167-8176.
22. Gilliss B, Malanga CJ, Pieper JO, Carlezon Jr WA (2002) Cocaine and SKF-82958 potentiate brain stimulation reward in Swiss-Webster mice. Psychopharmacology (Berl) 163:238-248.
23. Grech DM, Spealman RD, Bergman J (1996) Self-administration of D1 receptor agonists by squirrel monkeys. Psychopharmacology (Berl) 125:97-104.
24. Haney M, Collins ED, Ward AS, Foltin RW, Fischman MW (1999) Effect of selective dopamine D1 agonist (ABT-431) on smoked cocaine self-administration in humans. Psychopharmacology (Berl) 143:102-110.
25. Haney M, Ward AS, Foltin RW, Fischman MW (2001) Effects of ecopipam, a selective dopamine D1 antagonist, on smoked cocaine self-administration by humans. Psychopharmacology (Berl) 155:330-337.
26. Johansen PA, Hu XT, White FJ (1991) Relationship between D1 dopamine receptors, adenylate cyclase, and the electrophysiological responses of rat nucleus accumbens neurons. J Neural Transm Gen Sect 86:97-113.
27. Karasinska JM, George SR, El-Ghundi M, Fletcher PJ, O'Dowd BF (2000) Modification of dopamine D(1) receptor knockout phenotype in mice lacking both dopamine D(1) and D(3) receptors. Eur J Pharmacol 399:171-181.
28. Keefe KA, Gerfen CR (1995) D1-D2 dopamine receptor synergy in striatum: effects of intrastriatal infusions of dopamine agonists and antagonists on immediate early gene expression. Neuroscience 66:903-913.
29. 2 dopamine receptor-deficient mice is determined by gene dosage, genetic background, and developmental adaptations. J Neurosci 18:3470-3479.
30. Khroyan TV, Barrett-Larimore RL, Rowlett JK, Spealman RD (2000) Dopamine D1- and D2-like receptor mechanisms in relapse to cocaine-seeking behavior: effects of selective antagonists and agonists. J Pharmacol Exp Ther 294:680-687.
31. Kleven MS, Anthony EW, Woolverton WL (1990) Pharmacological characterization of the discriminative stimulus effects of cocaine in rhesus monkeys. J Pharmacol Exp Ther 254:312-317.
32. Koob GF (1992) Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol Sci 13:177-184.
33. Kuzmin A, Johansson B (2000) Reinforcing and neurochemical effects of cocaine: differences among C57, DBA, and 129 mice. Pharmacol Biochem Behav 65:399-406.
34. Mello NK, Negus SS (1996) Preclinical evaluation of pharmacotherapies for treatment of cocaine and opioid abuse using drug self-administration procedures. Neuropsychopharmacology 14:375-424.
35. Mendelson JH, Mello NK (1996) Management of cocaine abuse and dependence. N Engl J Med 334:965-972.
36. Miner LL (1997) Cocaine reward and locomotor activity in C57BL/6J and 129/SvJ inbred mice and their F1 cross. Pharmacol Biochem Behav 58:25-30.
37. Miner LL, Drago J, Chamberlain PM, Donovan D, Uhl GR (1995) Retained cocaine conditioned place preference in D1 receptor deficient mice. NeuroReport 6:2314-2316.
38. National Institute on Drug Abuse (2003) Epidemiologic trends in drug abuse. NIH publication number 03-5365 Washington, DC: National Institute on Drug Abuse.
39. Pettit HO, Ettenberg A, Bloom FE, Koob GF (1984) Destruction of dopamine in the nucleus accumbens selectively attenuates cocaine but not heroin self-administration in rats. Psychopharmacology 84:167-173.
40. Phillips TJ, Hen R, Crabbe JC (1999) Complications associated with genetic background effects in research using knockout mice. Psychopharmacology (Berl) 147:5-7.
41. 2 receptor knock-out mice. J Neurosci 22:9604-9611.
42. Ralph-Williams RJ, Lehmann-Masten V, Geyer MA (2003) Dopamine D1 rather than D2 receptor agonists disrupt prepulse inhibition of startle in mice. Neuropsychopharmacology 28:108-118.
43. Ralph RJ, Caine SB (2005) Dopamine D1 and D2 agonist effects on prepulse inhibition and locomotion: comparison of Sprague Dawley rats to Swiss-Webster, 129X1/SvJ, C57BL/6J, and DBA/2J mice. J Pharmacol Exp Ther 312:733-741.
44. Rassnick S, Stinus L, Koob GF (1993) The effects of 6-hydroxydopamine lesions of the nucleus accumbens and the mesolimbic dopamine system on oral self-administration of ethanol in the rat. Brain Res 623:16-24.
45. Rocha BA, Ator R, Emmett-Oglesby MW, Hen R (1997) Intravenous cocaine self-administration in mice lacking 5-HT1B receptors. Pharmacol Biochem Behav 57:407-412.
46. Rocha BA, Fumagalli F, Gainetdinov RR, Jones SR, Ator R, Giros B, Miller GW, Caron MG (1998) Cocaine self-administration in dopaminetransporter knockout mice. Nat Neurosci 1:132-137.
47. Romach MK, Glue P, Kampman K, Kaplan HL, Somer GR, Poole S, Clarke L, Coffin V, Cornish J, O'Brien CP, Sellers EM (1999) Attenuation of the euphoric effects of cocaine by the dopamine D1/D5 antagonist ecopipam (SCH 39166). Arch Gen Psychiatry 56:1101-1106.
48. Self DW, Stein L (1992) The D1 agonists SKF 82958 and SKF 77434 are self-administered by rats. Brain Res 582:349-352.
49. Self DW, Barnhart WJ, Lehman DA, Nestler EJ (1996) Opposite modulation of cocaine-seeking behavior by D1- and D2-like dopamine receptor agonists. Science 271:1586-1589.
50. Smith DR, Striplin CD, Geller AM, Mailman RB, Drago J, Lawler CP, Gallagher M (1998) Behavioural assessment of mice lacking D1A dopamine receptors. Neuroscience 86:135-146.
51. Spealman RD, Bergman J, Madras BK, Melia KF (1991) Discriminative stimulus effects of cocaine in squirrel monkeys: involvement of dopamine receptor subtypes. J Pharmacol Exp Ther 258:945-953.
52. Suto N, Tanabe LM, Austin JD, Creekmore E, Pham CT, Vezina P (2004) Previous exposure to psychostimulants enhances the reinstatement of cocaine seeking by nucleus accumbens AMPA. Neuropsychopharmacology 29:2149-2159.
53. Thomsen M, Caine SB (2005) Intravenous drug self-administration techniques in rats and mice. In: Current protocols in neuroscience unit 9.20, Supplement 32 (Skolnick P, ed), pp 1-40. Somerset, NJ: Wiley.
54. Thomsen M, Caine SB (2006) Cocaine self-administration under fixed and progressive ratio schedules of reinforcement: comparison of C57BL/6J, 129X1/SvJ, and 129S6/SvEvTack inbred mice. Psychopharmacology 184:145-154.
55. Thomsen M, Caine SB (2007) Intravenous drug self-administration techniques in mice: practical considerations. Behav Genet 37:101-118.
56. Wachtel SR, Hu XT, Galloway MP, White FJ (1989) D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems. Synapse 4:327-346.
57. Walters JR, Bergstrom DA, Carlson JH, Chase TN, Braun AR (1987) D1 dopamine receptor activation required for postsynaptic expression of D2 agonist effects. Science 236:719-722.
58. Waszczak BL, Martin LP, Finlay HE, Zahr N, Stellar JR (2002) Effects of individual and concurrent stimulation of striatal D1 and D2 dopamine receptors on electrophysiological and behavioral output from rat basal ganglia. J Pharmacol Exp Ther 300:850-861.
59. Weed MR, Woolverton WL (1995) The reinforcing effects of dopamine D1 receptor agonists in rhesus monkeys. J Pharmacol Exp Ther 275:1367-1374.
60. White FJ, Bednarz LM, Wachtel SR, Hjorth S, Brooderson RJ (1988) Is stimulation of both D1 and D2 receptors necessary for the expression of dopamine-mediated behaviors? Pharmacol Biochem Behav 30:189-193.
61. Wise RA, Bozarth MA (1987) Apsychomotor stimulant theory of addiction. Psychol Rev 94:469-492.
62. Witkin JM, Nichols DE, Terry P, Katz JL (1991) Behavioral effects of selective dopaminergic compounds in rats discriminating cocaine injections. J Pharmacol Exp Ther 257:706-713.
63. Woolverton WL, Goldberg LI, Ginos JZ (1984) Intravenous self-administration of dopamine receptor agonists by rhesus monkeys. J Pharmacol Exp Ther 230:678-683.
64. Xu M, Moratalla R, Gold LH, Hiroi N, Koob GF, Graybiel AM, Tonegawa S (1994a) Dopamine D1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediated behavioral responses. Cell 79:729-742.
65. Xu M, Hu XT, Cooper DC, Moratalla R, Graybiel AM, White FJ, Tonegawa S (1994b) Elimination of cocaine-induced hyperactivity and dopaminemediated neurophysiological effects in dopamine D1 receptor mutant mice. Cell 79:945-955.
66. Xu M, Guo Y, Vorhees CV, Zhang J (2000) Behavioral responses to cocaine and amphetamine administration in mice lacking the dopamine D1 receptor. Brain Res 852:198-207.
67. Zhang D, Zhang L, Tang Y, Zhang Q, Lou D, Sharp FR, Zhang J, Xu M (2005) Gene expression changes induced by repeated cocaine administration through the dopamine D1 receptors. Neuropsychopharmacology 30:1443-1454.
68. Zhang J, Zhang L, Jiao H, Zhang Q, Zhang D, Lou D, Katz J, Xu M (2006) c-fos facilitates acquisition and extinction of cocaine-induced persistent change. J Neurosci 26:13287-13296.
69. 3 receptors. J Neurosci 24:3344-3354.
70. Zhang Y, Mantsch JR, Schlussman SD, Ho A, Kreek MJ (2002) Conditioned place preference after single doses or "binge" cocaine in C57BL/6J and 129/J mice. Pharmacol Biochem Behav 73:655-662.